AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34524033 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Pump
Number of subjects: 165
Study 34524033 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 165
Study 34524033 — intervention group
Group type: EXPERIMENTAL
Intervention: Any technology (pump or CGM)
Number of subjects: 165
Study 34524033 — intervention group
Group type: COMPARATOR
Intervention: Multiple Daily Injections (MDI)
Number of subjects: 165
Study 34524033 — intervention group
Group type: COMPARATOR
Intervention: Blood Glucose Monitoring (BGM)
Number of subjects: 165
Study 32955948 — intervention group
Group type: EXPERIMENTAL
Intervention: 2GETHER program (relationship education and HIV prevention)
Number of subjects: 838
Study 32801301 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education principles assessment
Number of subjects: 108
Study 36202024 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 50
Study 36202024 — intervention group
Group type: COMPARATOR
Intervention: Guided Imagery (GI)
Number of subjects: 50
Study 33793299 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib 125 mg once daily for 13 cycles in addition to endocrine therapy (ET)
Number of subjects: 1250
Study 33793299 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 13 cycles in addition to endocrine therapy (ET)
Number of subjects: 1250
Study 32396510 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullar osteosynthesis using elastic stable intramedullary nailing (ESIN)
Number of subjects: 60
Study 32396510 — intervention group
Group type: COMPARATOR
Intervention: Plate osteosynthesis
Number of subjects: 60
Study 35868713 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD group
Number of subjects: 39
Study 35868713 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-HMD)
Number of subjects: 39
Study 32212829 — intervention group
Group type: EXPERIMENTAL
Intervention: CSEMSs
Number of subjects: 66
Study 32212829 — intervention group
Group type: COMPARATOR
Intervention: USEMSs
Number of subjects: 66
Study 34041608 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid hyrax appliance with miniscrews
Number of subjects: 35
Study 34041608 — intervention group
Group type: COMPARATOR
Intervention: Conventional hyrax expander with miniscrews
Number of subjects: 35
Study 33626934 — intervention group
Group type: EXPERIMENTAL
Intervention: PAL+FUL
Number of subjects: 0
Study 32521785 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 week peer‐led pain management program (PAP)
Number of subjects: 0
Study 32521785 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35841363 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate and apremilast combination therapy (Group A)
Number of subjects: 64
Study 35841363 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate monotherapy (Group B)
Number of subjects: 64
Study 34582171 — intervention group
Group type: EXPERIMENTAL
Intervention: Piecewise isothermal nucleic acid test (PINAT) for SARS-CoV-2
Number of subjects: 370
Study 34582171 — intervention group
Group type: EXPERIMENTAL
Intervention: Piecewise isothermal nucleic acid test (PINAT) for Influenza A
Number of subjects: 370
Study 36197272 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term extended nursing services plus atezolizumab (LTENS-ATZ)
Number of subjects: 126
Study 36197272 — intervention group
Group type: COMPARATOR
Intervention: Long-term conventional nursing plus atezolizumab (LTCN-ATZ)
Number of subjects: 126
Study 33746633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental trauma prevalence assessment
Number of subjects: 7902
Study 33746633 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of predisposing factors for dental trauma
Number of subjects: 7902
Study 33125702 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid
Number of subjects: 0
Study 33125702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35287501 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi Jin Bang (YJB) exercise
Number of subjects: 54
Study 35287501 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual exercise therapy (UET)
Number of subjects: 54
Study 35287501 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study 33280529 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 43
Study 33280529 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study 32660611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravulizumab plus Best Supportive Care (BSC)
Number of subjects: 270
Study 32660611 — intervention group
Group type: COMPARATOR
Intervention: Best Supportive Care (BSC) alone
Number of subjects: 270
Study 32660611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravulizumab plus BSC
Number of subjects: 270
Study 35714477 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0
Study 35714477 — intervention group
Group type: COMPARATOR
Intervention: Apalutamide
Number of subjects: 0
Study 32554760 — intervention group
Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil
Number of subjects: 70
Study 32554760 — intervention group
Group type: EXPERIMENTAL
Intervention: rituximab
Number of subjects: 70
Study 32554760 — intervention group
Group type: EXPERIMENTAL
Intervention: azathioprine
Number of subjects: 70
Study 32554760 — intervention group
Group type: EXPERIMENTAL
Intervention: IV immunoglobulin (IVIG)
Number of subjects: 70
Study 32554760 — intervention group
Group type: COMPARATOR
Intervention: multiple sclerosis (MS) disease-modifying agents
Number of subjects: 70
Study 32554760 — intervention group
Group type: EXPERIMENTAL
Intervention: overall treatments
Number of subjects: 70
Study 35697792 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS messages to parents
Number of subjects: 0
Study 35697792 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone calls to parents
Number of subjects: 0
Study 35697792 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (SMS messages and phone calls)
Number of subjects: 0
Study 34128044 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated estradiol to surge of ≤4 days
Number of subjects: 1891
Study 34128044 — intervention group
Group type: COMPARATOR
Intervention: Elevated estradiol to surge of >4 days
Number of subjects: 1891
Study 34128044 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular length ≤15 days
Number of subjects: 1891
Study 34128044 — intervention group
Group type: COMPARATOR
Intervention: Follicular length >15 days
Number of subjects: 1891
Study 32160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatricians' knowledge and practices regarding menstruation
Number of subjects: 462
Study 32160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatricians' practices regarding anticipatory guidance
Number of subjects: 462
Study 32160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatricians' practices regarding menstruation discussions
Number of subjects: 462
Study 32160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatricians' practices regarding menstrual cycle evaluation
Number of subjects: 462
Study 32160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Male pediatricians' practices
Number of subjects: 462
Study 32160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge gaps in menstruation-related topics
Number of subjects: 462
Study 34057540 — intervention group
Group type: EXPERIMENTAL
Intervention: bicortical CBT screws
Number of subjects: 20
Study 34057540 — intervention group
Group type: COMPARATOR
Intervention: pericortical CBT screws
Number of subjects: 20
Study 34773384 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT)
Number of subjects: 291
Study 34773384 — intervention group
Group type: COMPARATOR
Intervention: Conventional chest physiotherapy (control)
Number of subjects: 291
Study 32520418 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Beet+GFJ (250 mL grapefruit juice + 70 mL beetroot juice)
Number of subjects: 11
Study 32520418 — intervention group
Group type: COMPARATOR
Intervention: Active Beet+H2O (250 mL water + 70 mL beetroot juice)
Number of subjects: 11
Study 32520418 — intervention group
Group type: COMPARATOR
Intervention: Placebo Beet+GFJ (placebo beetroot juice + 250 mL grapefruit juice)
Number of subjects: 11
Study 32772246 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional (TRAD) training
Number of subjects: 28
Study 32772246 — intervention group
Group type: EXPERIMENTAL
Intervention: Accentuation eccentric loading (AEL) training
Number of subjects: 28
Study 32772246 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) training
Number of subjects: 28
Study 36104706 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) with 15 sessions
Number of subjects: 40
Study 36104706 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation alone
Number of subjects: 40
Study 33617341 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 9
Study 35044886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 88
Study 35044886 — intervention group
Group type: COMPARATOR
Intervention: Enriched Supportive Therapy (EST)
Number of subjects: 88
Study 35197335 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-optimised self-management of postpartum blood pressure via a smartphone app with algorithm-driven medication titration
Number of subjects: 200
Study 35197335 — intervention group
Group type: COMPARATOR
Intervention: Usual care by the healthcare team
Number of subjects: 200
Study 35197335 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-optimised self-management
Number of subjects: 200
Study 35197335 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 32353162 — intervention group
Group type: EXPERIMENTAL
Intervention: MGS0274 besylate (TS-134) at doses of 5–80 mg (single and multiple doses)
Number of subjects: 0
Study 32353162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34788830 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest hydrocortisone dose in the evening
Number of subjects: 39
Study 34788830 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest hydrocortisone dose in the morning
Number of subjects: 39
Study 34788830 — intervention group
Group type: COMPARATOR
Intervention: Both treatment strategies
Number of subjects: 39
Study 34593015 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported internet-delivered behaviour therapy (BIP TIC) for 10-12 weeks
Number of subjects: 220
Study 34593015 — intervention group
Group type: COMPARATOR
Intervention: Therapist-supported internet-delivered education (active control) for 10-12 weeks
Number of subjects: 220
Study 32195768 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g intrinsically L‐[1‐C]‐phenylalanine‐labeled casein protein before sleep (PRO)
Number of subjects: 36
Study 32195768 — intervention group
Group type: COMPARATOR
Intervention: Placebo (EX)
Number of subjects: 36
Study 32195768 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g intrinsically L‐[1‐C]‐phenylalanine‐labeled casein protein before sleep (EX + PRO)
Number of subjects: 36
Study 33476707 — intervention group
Group type: EXPERIMENTAL
Intervention: BIOSYNEX COVID‐19 BSS (IgG/IgM)
Number of subjects: 100
Study 33476707 — intervention group
Group type: EXPERIMENTAL
Intervention: Humasis COVID‐19 IgG/IgM Test
Number of subjects: 100
Study 33476707 — intervention group
Group type: EXPERIMENTAL
Intervention: LYHER COVID‐19 IgM/IgG Rapid Test
Number of subjects: 100
Study 33476707 — intervention group
Group type: EXPERIMENTAL
Intervention: SIENNA™ COVID‐19 (IgG/IgM) Rapid Test Cassette
Number of subjects: 100
Study 33476707 — intervention group
Group type: EXPERIMENTAL
Intervention: NG‐BIOTECH COVID‐19 (IgG/IgM)
Number of subjects: 100
Study 33176462 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885
Study 33176462 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study 35774045 — intervention group
Group type: EXPERIMENTAL
Intervention: CLS02021 cream
Number of subjects: 50
Study 35774045 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 50
Study 33711654 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 0
Study 33711654 — intervention group
Group type: COMPARATOR
Intervention: Placebo (40 μg d3‐vitamin)
Number of subjects: 0
Study 33002541 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiation Therapy (SABR)
Number of subjects: 0
Study 33002541 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study 32940131 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT) with changing ratios
Number of subjects: 81
Study 32940131 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT)
Number of subjects: 81
Study 32940131 — intervention group
Group type: COMPARATOR
Intervention: Tied-Belt Treadmill (TBT)
Number of subjects: 81
Study 35579642 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (initially 0.6-0.8 mg/kg/d, maximum 48 mg/d, weaning by 8 mg/d/mo)
Number of subjects: 503
Study 35579642 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (reduced dose 0.4 mg/kg/d, maximum 32 mg/d, weaning by 4 mg/d/mo)
Number of subjects: 503
Study 35579642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 503
Study 35579642 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone
Number of subjects: 503
Study 34158518 — intervention group
Group type: EXPERIMENTAL
Intervention: ID‐JPL934
Number of subjects: 112
Study 34158518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 36098968 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3, 2000 IU/d
Number of subjects: 25057
Study 36098968 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids, 1 g/d
Number of subjects: 25057
Study 36098968 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 25057
Study 33630408 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate supplementation (300 mg potassium nitrate/day)
Number of subjects: 231
Study 33630408 — intervention group
Group type: COMPARATOR
Intervention: Placebo (300 mg potassium chloride/day)
Number of subjects: 231
Study 33129278 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct patient recruitment materials
Number of subjects: 0
Study 33129278 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of community pharmacists
Number of subjects: 0
Study 33129278 — intervention group
Group type: EXPERIMENTAL
Intervention: Free medications
Number of subjects: 0
Study 33688084 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCs with explanation about 'switching completely'
Number of subjects: 2914
Study 33688084 — intervention group
Group type: COMPARATOR
Intervention: MRCs with explanation absent
Number of subjects: 2914
Study 33688084 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2914
Study 33688084 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCs with certain language
Number of subjects: 2914
Study 33688084 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCs with hypothetical language
Number of subjects: 2914
Study 33688084 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCs highlighting reduced risk for a single disease
Number of subjects: 2914
Study 33688084 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCs highlighting reduced risk for multiple diseases
Number of subjects: 2914
Study 33688084 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCs
Number of subjects: 2914
Study 33515740 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic inulin (16 g/d)
Number of subjects: 106
Study 33515740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 106
Study 33515740 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic inulin
Number of subjects: 106
Study 35924292 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sheath removal (n = 171)
Number of subjects: 349
Study 35924292 — intervention group
Group type: COMPARATOR
Intervention: Late sheath removal (n = 178)
Number of subjects: 349
Study 33909725 — intervention group
Group type: EXPERIMENTAL
Intervention: Human chorionic amniotic membrane
Number of subjects: 8
Study 33909725 — intervention group
Group type: COMPARATOR
Intervention: Platelet-rich fibrin
Number of subjects: 8
Study 34479461 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal invasive extracorporeal circulation (MiECC)
Number of subjects: 240
Study 34479461 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation (CECC)
Number of subjects: 240
Study 34479461 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 240
Study 32912659 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual grand rounds (VGR)
Number of subjects: 18
Study 32078409 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person social communication skills training (n = 17)
Number of subjects: 51
Study 32078409 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth social communication skills training (n = 19)
Number of subjects: 51
Study 32078409 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication partners trained (in-person or telehealth)
Number of subjects: 51
Study 32078409 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (n = 15)
Number of subjects: 51
Study 35385798 — intervention group
Group type: EXPERIMENTAL
Intervention: Alert intervention
Number of subjects: 1310
Study 35385798 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1310
Study 33945526 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash incentives (US$7) for retesting at 3 and 6 months (total US$14)
Number of subjects: 524
Study 33945526 — intervention group
Group type: EXPERIMENTAL
Intervention: Deposit contracts (voluntary deposit of US$6 at baseline and at 3 months)
Number of subjects: 524
Study 33945526 — intervention group
Group type: COMPARATOR
Intervention: No incentive (control)
Number of subjects: 524
Study 33237182 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastibell® (PB group)
Number of subjects: 149
Study 33237182 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional technique (CV group)
Number of subjects: 149
Study 33237182 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional with subcuticular stitches (SC group)
Number of subjects: 149
Study 33237182 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 149
Study 35344750 — intervention group
Group type: EXPERIMENTAL
Intervention: Surufatinib
Number of subjects: 242
Study 35344750 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 242
Study 35786512 — intervention group
Group type: EXPERIMENTAL
Intervention: 5,000 IU of vitamin D
Number of subjects: 54
Study 35786512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 33515938 — intervention group
Group type: COMPARATOR
Intervention: Alectinib 600 mg twice daily
Number of subjects: 0
Study 33515938 — intervention group
Group type: COMPARATOR
Intervention: Alectinib 300 mg twice daily
Number of subjects: 0
Study 32702299 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 10^11 viral particles
Number of subjects: 508
Study 32702299 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 × 10^10 viral particles
Number of subjects: 508
Study 32702299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 508
Study 36293616 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic Diet (VLCKD)
Number of subjects: 268
Study 36293616 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet (MD)
Number of subjects: 268
Study 32627352 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified human pancreatic islets (PHPI) transplantation
Number of subjects: 24
Study 33360163 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-222 at 300 mg/L
Number of subjects: 28
Study 33360163 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-222 at 100 mg/L
Number of subjects: 28
Study 33360163 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-222 at 200 mg/L
Number of subjects: 28
Study 33360163 — intervention group
Group type: COMPARATOR
Intervention: Non-anesthetized
Number of subjects: 28
Study 33360163 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-222 (all concentrations)
Number of subjects: 28
Study 32500393 — intervention group
Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 158
Study 32500393 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet drink
Number of subjects: 158
Study 32500393 — intervention group
Group type: COMPARATOR
Intervention: Control (SSB consumption)
Number of subjects: 158
Study 33210975 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL, Photrexa + KXL combination product)
Number of subjects: 100
Study 33210975 — intervention group
Group type: COMPARATOR
Intervention: No corneal collagen cross-linking (no CXL)
Number of subjects: 100
Study 36459731 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 459
Study 36459731 — intervention group
Group type: EXPERIMENTAL
Intervention: F/V diet
Number of subjects: 459
Study 36459731 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 459
Study 33111977 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex decongestive physiotherapy (CDP)
Number of subjects: 21
Study 33111977 — intervention group
Group type: EXPERIMENTAL
Intervention: Home program
Number of subjects: 21
Study 33111977 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study 32649494 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent suture
Number of subjects: 204
Study 32649494 — intervention group
Group type: COMPARATOR
Intervention: Delayed absorbable suture
Number of subjects: 204
Study 35189818 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (AS-AQ)
Number of subjects: 242
Study 35189818 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 242
Study 33989351 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided DNTP technique
Number of subjects: 256